Patterns of locoregional failure in locally advanced non-small cell lung cancer treated with definitive conformal radiotherapy: Results from the Gating 2006 trial

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

Jeffrey D. Bradley, Rebecca Paulus, Ritsuko Komaki et al. · The Lancet Oncology · 2015 · 2K citations · Full text

Medicine, Oncology, Radiation Oncology +17

Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

Ursula Nestle, Stephanie Kremp, Andrea Schaefer-Schuler et al. · PubMed · 2005 · 615 citations

Medicine, Nuclear Medicine, Oncology +17

Evaluation of microscopic tumor extension in non–small-cell lung cancer for three-dimensional conformal radiotherapy planning

P. Giraud, Martine Antoine, Anne Larrouy et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 437 citations

Medicine, Oncology, Radiation Oncology +15

The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer

Wouter van Elmpt, Dirk De Ruysscher, Anke van der Salm et al. · Radiotherapy and Oncology · 2012 · 229 citations

Medicine, Nuclear Medicine, Oncology +10

European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer

Dirk De Ruysscher, Corinne Faivre‐Finn, D.S. Moeller et al. · Radiotherapy and Oncology · 2017 · 214 citations · Full text

Medicine, Oncology, Radiation Oncology +16